Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nerve regeneration device in Phase III trials:

This article was originally published in Clinica

Executive Summary

Integra LifeSciences has begun Phase III trials of its peripheral nerve regeneration conduit in Europe. The trials will focus on restoring function following traumatic injury of the median nerve and will be carried out at the Hospital Clinic de Barcelona in Spain and at the Rigshospitalet in Copenhagen, Denmark. The Plainsboro, New Jersey-based company said it expects the trials to last approximately two years, after which it will seek approval for the product in the US and Europe.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel